Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elliot B Tapper

Showing results (11-20 of 348) with videos related to

Pageof 35
Sort By:
Hepatology (Baltimore, Md.)|May 10, 2023
Letter to the Editor: Modeling concernsElliot B Tapper
JAMA Internal Medicine|May 5, 2015
Lactulose vs Polyethylene Glycol for Treatment of Hepatic EncephalopathyElliot B Tapper
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 14, 2021
ReplyElliot B Tapper
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 6, 2020
A Trial of Ornithine Phenylacetate and the Arc of Ammonia's History in the Management of Overt Hepatic EncephalopathyElliot B Tapper
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 23, 2016
Building Effective Quality Improvement Programs for Liver Disease: A Systematic Review of Quality Improvement InitiativesElliot B Tapper
Gastroenterology & Hepatology|March 3, 2023
Use of Angiotensin-Converting Enzyme Inhibitors in Patients With Liver DiseaseElliot B Tapper
Gastroenterology Report|July 17, 2015
The efficacy and safety profile of albumin administration for patients with cirrhosis at high risk of hepatorenal syndrome is dose dependentYuliya Afinogenova, Elliot B Tapper
The Lancet. Gastroenterology & Hepatology|December 22, 2018
Driving in the dark: cirrhosis in young adultsGhideon Ezaz, Elliot B Tapper
Hepatology (Baltimore, Md.)|December 25, 2015
Weight loss results in significant improvements in quality of life for patients with nonalcoholic fatty liver disease: A prospective cohort studyElliot B Tapper, Michelle Lai
The Lancet. Gastroenterology & Hepatology|November 19, 2017
Towards patient-centred and cost-effective care for patients with cirrhosis and ascitesMary Thomson, Elliot B Tapper
Pageof 35

Showing results (11-20 of 348) with videos related to

Sort By:
Pageof 35
Hepatology (Baltimore, Md.)|May 10, 2023
Letter to the Editor: Modeling concernsElliot B Tapper
JAMA Internal Medicine|May 5, 2015
Lactulose vs Polyethylene Glycol for Treatment of Hepatic EncephalopathyElliot B Tapper
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 14, 2021
ReplyElliot B Tapper
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 6, 2020
A Trial of Ornithine Phenylacetate and the Arc of Ammonia's History in the Management of Overt Hepatic EncephalopathyElliot B Tapper
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 23, 2016
Building Effective Quality Improvement Programs for Liver Disease: A Systematic Review of Quality Improvement InitiativesElliot B Tapper
Gastroenterology & Hepatology|March 3, 2023
Use of Angiotensin-Converting Enzyme Inhibitors in Patients With Liver DiseaseElliot B Tapper
Gastroenterology Report|July 17, 2015
The efficacy and safety profile of albumin administration for patients with cirrhosis at high risk of hepatorenal syndrome is dose dependentYuliya Afinogenova, Elliot B Tapper
The Lancet. Gastroenterology & Hepatology|December 22, 2018
Driving in the dark: cirrhosis in young adultsGhideon Ezaz, Elliot B Tapper
Hepatology (Baltimore, Md.)|December 25, 2015
Weight loss results in significant improvements in quality of life for patients with nonalcoholic fatty liver disease: A prospective cohort studyElliot B Tapper, Michelle Lai
The Lancet. Gastroenterology & Hepatology|November 19, 2017
Towards patient-centred and cost-effective care for patients with cirrhosis and ascitesMary Thomson, Elliot B Tapper
Pageof 35